OVERSEA CHINESE BANKING Corp Ltd Has $944,000 Position in HCA Healthcare, Inc. (NYSE:HCA)

OVERSEA CHINESE BANKING Corp Ltd raised its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 7.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,144 shares of the company’s stock after buying an additional 221 shares during the quarter. OVERSEA CHINESE BANKING Corp Ltd’s holdings in HCA Healthcare were worth $944,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of HCA. MML Investors Services LLC grew its position in shares of HCA Healthcare by 31.7% in the 3rd quarter. MML Investors Services LLC now owns 17,816 shares of the company’s stock valued at $7,241,000 after purchasing an additional 4,285 shares during the period. Meritage Group LP acquired a new position in shares of HCA Healthcare in the 3rd quarter valued at approximately $150,548,000. Galvin Gaustad & Stein LLC acquired a new position in shares of HCA Healthcare in the 4th quarter valued at approximately $18,044,000. Alpha DNA Investment Management LLC acquired a new position in shares of HCA Healthcare in the 3rd quarter valued at approximately $869,000. Finally, NRI Wealth Management LC acquired a new position in HCA Healthcare during the 4th quarter worth approximately $2,896,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now owns 15,412 shares in the company, valued at $4,971,757.08. The trade was a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 1.60% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on HCA shares. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $405.00 price target on shares of HCA Healthcare in a research report on Monday, January 27th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $380.00 price target on shares of HCA Healthcare in a research report on Tuesday, December 17th. Wells Fargo & Company cut HCA Healthcare from an “equal weight” rating to an “underweight” rating and dropped their price objective for the stock from $400.00 to $320.00 in a research note on Monday, November 25th. Morgan Stanley dropped their price objective on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research note on Tuesday, December 17th. Finally, Truist Financial dropped their price objective on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $385.67.

HCA Healthcare Stock Up 1.3 %

Shares of NYSE HCA opened at $334.42 on Thursday. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The stock has a market capitalization of $82.34 billion, a P/E ratio of 15.22, a PEG ratio of 1.10 and a beta of 1.68. The stock’s fifty day moving average is $320.53 and its 200 day moving average is $343.97.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the previous year, the company earned $5.90 EPS. Sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be given a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.86%. The ex-dividend date of this dividend is Monday, March 17th. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s payout ratio is currently 13.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.